Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
about
Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbancesDiagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel DiseaseStructural brain lesions in inflammatory bowel diseaseGlucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implicationsToxic optic neuropathies: an updated reviewInflammatory bowel disease: an increased risk factor for neurologic complicationsMultiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!Validation and validity of diagnoses in the General Practice Research Database: a systematic review.Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.Optic neuritis associated with adalimumab in the treatment of uveitis.Extraintestinal manifestations and complications in inflammatory bowel diseases.Neurological disorders and inflammatory bowel diseasesDevelopment of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.Environmental risk factors in multiple sclerosis.Primary enteric-type mucinous adenocarcinoma of the urethra in a patient with ulcerative colitis.The anti-inflammatory activity of a novel fused-cyclopentenone phosphonate and its potential in the local treatment of experimental colitis.Sudden blindness in a child with Crohn's diseaseExome analysis of patients with concurrent pediatric inflammatory bowel disease and autoimmune disease.Histologically confirmed case of cerebral vasculitis associated with Crohn's disease--a case report.Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patientsInfliximab in the treatment of Crohn's disease.A De Novo Arisen Case of Primary Adrenal Insufficiency in an Adolescent Patient With Crohn Disease: A Case report.A Case of Cerebral Vasculitis Associated with Ulcerative Colitis.Neurologic manifestations of ulcerative colitis.Takayasu arteritis associated with ulcerative colitis and optic neuritis: first case in Korea.Multiple sclerosis patients have a distinct gut microbiota compared to healthy controlsOptic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.Therapeutic options in acute severe ulcerative colitis.Association of Demyelinating and Inflammatory Bowel Diseases: A Case Series and Overview of the Literature.CNS Demyelination with TNF-α BlockersLong-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts.Occurrence of demyelinating diseases after anti-TNFα treatment of inflammatory bowel disease: A Danish Crohn Colitis Database study.Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature.Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics.Biologic therapies: lessons from multiple sclerosis.Multiple sclerosis and pain.Orbital and optic nerve complications of inflammatory bowel disease.Cytokine control of inflammation and repair in the pathology of multiple sclerosis.Ocular complications associated with systemic medications used in allergy/immunology practice.
P2860
Q21560928-2957F184-EB89-486F-A868-BAF8637562E5Q22241416-9BEBF6F2-2FCD-4DAF-806C-CBDB257E944AQ26776172-C5C6A332-211A-4117-A1E0-C500199456EAQ26866110-EE5050ED-D159-4401-B45A-01A16007D3D7Q27025010-EADB1602-EA79-4408-8F48-3224ABE389AEQ27690759-00D344D8-8DA2-40AD-9E65-5D57F81868E9Q30571620-2FCDD745-B1CD-4CD4-9DE7-B93A3A8D61C3Q33588222-6944D0F2-FE18-4160-9F31-519CF42E03E0Q33626027-C2659D14-6C62-417C-9A22-82FBE800146CQ33681462-E3475908-B5CB-4145-B70A-4A08F7943EE9Q33866998-B49D1E20-9C11-4D66-B50E-48D1BEE4B8B7Q33958822-8D07A6FC-6D3A-42A4-B142-DE7315307507Q34098754-07AE99DD-82D5-40FA-9306-7A781C731FD6Q34100847-CB340EE2-A986-4728-85D6-EFE9F952BA20Q34622042-A4D39117-5B93-4640-98E0-CB1BC2EF32A9Q35534551-B49A8619-B9A7-4EB8-AD42-5E1887124E62Q35545760-0965E296-66A7-44E6-86AE-1BC7867592DDQ35670620-F7CA828F-6661-4182-AF0C-83E58BAEBD94Q35782241-C325B65F-AA41-4BFD-AAA8-CCEB7302457BQ35811221-D84EE6A2-7209-4A8C-AC02-CA80D7C06DFFQ35919228-38D6B12E-811F-49D7-9A70-FA852F20C009Q36194145-88BA3C8C-448B-4769-B3AF-2F958164C265Q36236295-9C7325BF-C02E-4162-B225-80229916B73BQ36793208-C7CE368B-69D0-4490-983C-B22C3501B7BBQ37015317-CE3F5FD4-D715-4C2C-82FB-340021135992Q37040077-107F9F2A-868F-4A4B-A285-76AA6717AB39Q37118403-47223126-3D5D-4526-957F-92BF268A9542Q37223169-E3251749-C434-4F63-AAFB-1EFD3FB26CAAQ37345935-943DF25A-A7F5-486F-8750-6679E7AF0E21Q37703827-504E7A11-8267-4878-BDE3-A97F237124FEQ37719132-F51C8829-B8EC-4DC4-9D4B-E6279A8333EFQ37781314-0C983B7E-9C00-4466-9D09-5C10F21A2984Q37822506-ED455C61-A606-4E1C-B064-2A82F0880500Q37977994-E2D74057-7F9A-4007-9B40-4602A7A52572Q38007126-C779F321-274E-499D-95DA-E2AA477A389DQ38026399-2A195C10-6063-4324-9C80-121B2914529CQ38036427-29D0E41E-5D0E-450B-ADB1-0F246A166799Q38053517-E3AAE9CD-2942-4853-A787-3343CFF583BEQ38067389-1CD7ACDF-F061-47D7-8D7E-C32B4AA9FC51Q38071560-A38B28D6-8A31-4124-994F-953B3D41C73D
P2860
Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
@en
type
label
Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
@en
prefLabel
Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
@en
P1433
P1476
Increased risk for demyelinating diseases in patients with inflammatory bowel disease
@en
P2093
Gauree Gupta
James D Lewis
P304
P356
10.1053/J.GASTRO.2005.06.022
P407
P577
2005-09-01T00:00:00Z